OpenLB
Open Library of Bioscience
Advanced Search
Emerging microbes & infections
Dec, 2020;9 (1): 761-770.

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.

Yong Xiong, Yuan Liu, Liu Cao, Dehe Wang, Ming Guo, Ao Jiang, Dong Guo, Wenjia Hu, Jiayi Yang, Zhidong Tang, Honglong Wu, Yongquan Lin, Meiyuan Zhang, Qi Zhang, Mang Shi, Yingle Liu, Yu Zhou, Ke Lan, Yu Chen
Author Information
  1. Yong Xiong: State Key Laboratory of Virology, Department of Infectious Disease, Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China.
  2. Yuan Liu: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  3. Liu Cao: The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
  4. Dehe Wang: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  5. Ming Guo: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  6. Ao Jiang: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  7. Dong Guo: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  8. Wenjia Hu: State Key Laboratory of Virology, Department of Infectious Disease, Zhongnan Hospital, Wuhan University, Wuhan, People's Republic of China.
  9. Jiayi Yang: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  10. Zhidong Tang: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  11. Honglong Wu: BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China.
  12. Yongquan Lin: BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China. ORCID
  13. Meiyuan Zhang: BGI PathoGenesis Pharmaceutical Technology, Shenzhen, People's Republic of China.
  14. Qi Zhang: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China. ORCID
  15. Mang Shi: The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
  16. Yingle Liu: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  17. Yu Zhou: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  18. Ke Lan: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China.
  19. Yu Chen: State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People's Republic of China. ORCID
PMID: 32228226 DOI: 10.1080/22221751.2020.1747363

Abstract

Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.

Keywords

COVID-19 cytokine inflammation lymphopenia transcriptome profiling

References

  1. BMC Biol. 2019 Jul 18;17(1):59 pubmed:31319842
  2. Genomics Proteomics Bioinformatics. 2017 Feb;15(1):14-18 pubmed:28387199
  3. J Med Virol. 2020 Apr;92(4):418-423 pubmed:31967327
  4. Cell Rep. 2019 Feb 5;26(6):1627-1640.e7 pubmed:30726743
  5. Lancet. 2003 Jun 7;361(9373):1985 pubmed:12801759
  6. Nucleic Acids Res. 2020 Jan 8;48(D1):D756-D761 pubmed:31691824
  7. Nature. 2020 Mar;579(7798):270-273 pubmed:32015507
  8. Immunol Res. 2014 Aug;59(1-3):118-28 pubmed:24845462
  9. Viruses. 2019 Oct 18;11(10): pubmed:31635238
  10. Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7 pubmed:15657466
  11. Bioinformatics. 2012 Aug 15;28(16):2184-5 pubmed:22743226
  12. Annu Rev Med. 2017 Jan 14;68:387-399 pubmed:27576010
  13. Bioinformatics. 2014 Apr 1;30(7):923-30 pubmed:24227677
  14. Nat Commun. 2019 Dec 13;10(1):5711 pubmed:31836714
  15. J Med Virol. 2005 Feb;75(2):185-94 pubmed:15602737
  16. Lancet Respir Med. 2020 Apr;8(4):420-422 pubmed:32085846
  17. PLoS Pathog. 2008 Dec;4(12):e1000240 pubmed:19079579
  18. Cell Host Microbe. 2016 Feb 10;19(2):181-93 pubmed:26867177
  19. Bioinformatics. 2009 Jan 15;25(2):288-9 pubmed:19033274
  20. Annu Rev Immunol. 2014;32:659-702 pubmed:24655300
  21. JAMA. 2020 Mar 17;323(11):1061-1069 pubmed:32031570
  22. Nucleic Acids Res. 2019 Jan 8;47(D1):D590-D595 pubmed:30321428
  23. J Infect Dis. 2014 May 1;209(9):1331-42 pubmed:24065148
  24. N Engl J Med. 2020 Apr 30;382(18):1708-1720 pubmed:32109013
  25. PLoS Med. 2006 Sep;3(9):e343 pubmed:16968120
  26. OMICS. 2012 May;16(5):284-7 pubmed:22455463
  27. Genome Biol. 2014;15(12):550 pubmed:25516281
  28. Semin Immunopathol. 2016 Jul;38(4):471-82 pubmed:26965109
  29. J Exp Med. 2005 Aug 1;202(3):415-24 pubmed:16043521
  30. Pediatrics. 2004 Jan;113(1 Pt 1):e7-14 pubmed:14702488
  31. Infect Immun. 2004 Aug;72(8):4410-5 pubmed:15271897
  32. Med Hypotheses. 2008 Aug;71(2):298-301 pubmed:18448259
  33. Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3799-804 pubmed:24572573
  34. J Med Virol. 2006 Apr;78(4):417-24 pubmed:16482545
  35. Immunity. 2017 Nov 21;47(5):903-912.e4 pubmed:29126797
  36. Emerg Microbes Infect. 2020 Dec;9(1):313-319 pubmed:32020836
  37. PLoS Pathog. 2017 Feb 16;13(2):e1006155 pubmed:28207896
  38. Nat Rev Microbiol. 2016 Aug;14(8):523-34 pubmed:27344959
  39. Bioinformatics. 2013 Jan 1;29(1):15-21 pubmed:23104886
  40. Lancet. 2020 Feb 15;395(10223):497-506 pubmed:31986264
  41. Int J Infect Dis. 2013 Feb;17(2):e76-83 pubmed:23069683
  42. Lancet. 2020 Feb 15;395(10223):473-475 pubmed:32043983
  43. BMJ. 2003 Sep 13;327(7415):620 pubmed:12969939
  44. Lancet. 2020 Feb 15;395(10223):507-513 pubmed:32007143
  45. Nucleic Acids Res. 2020 Jan 8;48(D1):D24-D33 pubmed:31702008
  46. J Immunol. 2008 Feb 1;180(3):1903-12 pubmed:18209088
  47. Clin Infect Dis. 2003 Sep 15;37(6):857-9 pubmed:12955652
  48. Cell Host Microbe. 2016 Feb 10;19(2):139-41 pubmed:26867172
  49. Nature. 2020 Mar;579(7798):265-269 pubmed:32015508

MeSH Term

Apoptosis
Betacoronavirus
Bronchoalveolar Lavage Fluid
COVID-19
Chemokines
Coronavirus Infections
Cytokines
Humans
Leukocytes, Mononuclear
Lymphopenia
Pandemics
Pneumonia, Viral
RNA-Seq
SARS-CoV-2
Signal Transduction
Transcriptome
Tumor Suppressor Protein p53

Chemicals

Chemokines
Cytokines
TP53 protein, human
Tumor Suppressor Protein p53
Journal Article

Links to CNCB-NGDC Resources

BioProject: PRJCA002326 (Transcriptome of patients infected with SARS-CoV-2)
GSA: CRA002390 (Transcriptome of patients infected with SARS-CoV-2)

Word Cloud